DZ3165A1 - Composition alimentaire ou pharmaceutique utiliseepour prevenir ou traiter l'hyperoxalurie. - Google Patents

Composition alimentaire ou pharmaceutique utiliseepour prevenir ou traiter l'hyperoxalurie.

Info

Publication number
DZ3165A1
DZ3165A1 DZ003165A DZ003165A DZ3165A1 DZ 3165 A1 DZ3165 A1 DZ 3165A1 DZ 003165 A DZ003165 A DZ 003165A DZ 003165 A DZ003165 A DZ 003165A DZ 3165 A1 DZ3165 A1 DZ 3165A1
Authority
DZ
Algeria
Prior art keywords
hyperoxaluria
treat
food
prevent
pharmaceutical composition
Prior art date
Application number
DZ003165A
Other languages
English (en)
Inventor
Simone Claudio De
Original Assignee
Mendes Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mendes Srl filed Critical Mendes Srl
Application granted granted Critical
Publication of DZ3165A1 publication Critical patent/DZ3165A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/065—Microorganisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/04—Drugs for disorders of the urinary system for urolithiasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Microbiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Steroid Compounds (AREA)
DZ003165A 1999-05-28 2000-05-24 Composition alimentaire ou pharmaceutique utiliseepour prevenir ou traiter l'hyperoxalurie. DZ3165A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1999RM000338A IT1309427B1 (it) 1999-05-28 1999-05-28 Composizione dietetica o farmaceutica utile per la prevenzione o iltrattamento dell'iperossaluria e suo uso
PCT/IT2000/000213 WO2000072855A2 (fr) 1999-05-28 2000-05-24 Composition alimentaire ou pharmaceutique utilisee pour prevenir ou traiter l'hyperoxalurie

Publications (1)

Publication Number Publication Date
DZ3165A1 true DZ3165A1 (fr) 2000-12-07

Family

ID=11406789

Family Applications (1)

Application Number Title Priority Date Filing Date
DZ003165A DZ3165A1 (fr) 1999-05-28 2000-05-24 Composition alimentaire ou pharmaceutique utiliseepour prevenir ou traiter l'hyperoxalurie.

Country Status (34)

Country Link
US (2) US6562336B2 (fr)
EP (1) EP1181027B1 (fr)
JP (1) JP4737836B2 (fr)
KR (1) KR100781703B1 (fr)
CN (1) CN100350919C (fr)
AR (1) AR024555A1 (fr)
AT (1) ATE265857T1 (fr)
AU (1) AU773459B2 (fr)
BR (1) BR0011038B1 (fr)
CA (1) CA2373255C (fr)
CZ (1) CZ20014076A3 (fr)
DE (1) DE60010456T2 (fr)
DK (1) DK1181027T3 (fr)
DZ (1) DZ3165A1 (fr)
EA (1) EA004257B1 (fr)
EE (1) EE200100618A (fr)
ES (1) ES2219344T3 (fr)
HK (1) HK1048066B (fr)
HU (1) HU225134B1 (fr)
IL (3) IL146703A0 (fr)
IS (1) IS6150A (fr)
IT (1) IT1309427B1 (fr)
MA (1) MA26790A1 (fr)
MX (1) MXPA01012184A (fr)
NO (1) NO20015782L (fr)
NZ (1) NZ516020A (fr)
PL (1) PL352014A1 (fr)
PT (1) PT1181027E (fr)
SI (1) SI1181027T1 (fr)
SK (1) SK16612001A3 (fr)
TR (1) TR200103439T2 (fr)
UA (1) UA71621C2 (fr)
WO (1) WO2000072855A2 (fr)
ZA (1) ZA200110504B (fr)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1283225B1 (it) * 1996-03-11 1998-04-16 Renata Maria Anna Ve Cavaliere Ceppi di batteri, composizione farmaceutica contenente uno o piu' di tali ceppi e uso dei medesimi per la prevenzione e la terapia delle
US8486389B2 (en) * 1997-05-23 2013-07-16 Oxthera, Inc. Compositions and methods for treating or preventing oxalate-related disease
US8697051B2 (en) * 1999-06-09 2014-04-15 Vsl Pharmaceuticals Inc. Composition comprising alkaline sphingomyelinase for use as a dietetic preparation, food supplement or pharmaceutical product
ITRM20010763A1 (it) * 2001-12-21 2003-06-21 Simone Claudio De Nuovo ceppo di batterio lattico e composizioni commestibili, farmaci e prodotti veterinari che lo contengono.
US20050074442A1 (en) * 2002-03-13 2005-04-07 Natarajan Ranganathan Compositions and methods for augmenting kidney function
US11103542B2 (en) 2002-03-13 2021-08-31 Kibow Biotech, Inc. Composition and method for maintaining healthy kidney function
US9655932B2 (en) 2002-03-13 2017-05-23 Kibow Biotech, Inc. Composition and method for preventing or treating gout or hyperuricemia
EP1649863A1 (fr) * 2003-06-24 2006-04-26 Otsuka Pharmaceutical Co., Ltd. Composition pour diminuer le taux d'acide urique serique
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
WO2005089564A1 (fr) 2004-03-19 2005-09-29 Danisco A/S Composition emulsifiante a raccourcir
US7468182B2 (en) * 2004-10-27 2008-12-23 North Carolina State University Lactobacillus acidophilus nucleic acids and uses thereof
AU2006253007B2 (en) 2005-05-31 2012-12-20 Alimentary Health Ltd Feline probiotic Bifidobacteria
EP2261323A1 (fr) 2005-05-31 2010-12-15 The Iams Company Lactobacilles probiotiques félins
WO2007070052A2 (fr) * 2005-12-14 2007-06-21 Oxthera, Inc. Compositions pharmaceutiques et méthodes destinées à traiter ou prévenir une maladie associée à l'oxalate
JP5558002B2 (ja) 2005-12-16 2014-07-23 オクセラ インコーポレイテッド シュウ酸塩低減化のための組成物および方法
US20080241226A1 (en) * 2007-03-27 2008-10-02 Abeln Susan L Methods and Kits For Administering Probiotics
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
CN101606952B (zh) * 2008-06-17 2012-09-19 上海交通大学医学院附属第三人民医院 乳双歧杆菌在制备预防泌尿系统结石药物中的应用
US9283252B2 (en) 2008-09-30 2016-03-15 Meiji Co., Ltd. Lactic acid bacterium having high oxalic acid decomposition ability
CN101554237B (zh) * 2009-03-16 2013-11-06 武汉康复得生物科技有限公司 植物纤维或微生物不溶组分中的草酸降解酶的制备方法
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
IT1403661B1 (it) 2011-01-28 2013-10-31 Probiotical Spa Composizione effervescente in forma solida per uso in applicazioni vaginali per il trattamento di infezioni vaginali.
ITMI20110793A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri probiotici e composizione sinbiotica contenente gli stessi destinata alla alimentazione dei neonati.
ITMI20110792A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri appartenenti al genere bifidobacterium per uso nel trattamento della ipercolesterolemia.
ITMI20110791A1 (it) 2011-05-09 2012-11-10 Probiotical Spa Ceppi di batteri in grado di metabolizzare gli ossalati.
ITRM20110477A1 (it) 2011-09-09 2013-03-10 Giovanni Mogna Composizione comprendente n-acetilcisteina e/o lisozima microincapsulato gastroprotetto in associazione con batteri probiotici in grado di ripristinare l'effetto barriera proprio dello stomaco che viene perso durante il trattamento farmacologico dell
ITMI20111718A1 (it) 2011-09-23 2013-03-24 Probiotical Spa Un materiale impermeabile alla umidita e allo ossigeno per confezionare prodotti dietetici, cosmetici e specialita medicinali.
ITMI20121173A1 (it) * 2012-07-04 2014-01-05 Neupharma Srl Composizioni dietetiche e/o farmaceutiche comprendenti ceppi di lactobacillus e bifidobacterium capaci di degradare gli ossalati e di indurre una risposta immunitaria di tipo anti-infiammatorio
ITMI20130795A1 (it) * 2013-05-14 2014-11-15 Probiotical Spa Composizione comprendente batteri lattici e/o bifidobatteri per uso nel trattamento preventivo e/o curativo delle infezioni batteriche e/o delle infiammazioni del tratto urinario e/o della prostata che sono la causa di prostatiti e ipertrofia prostat
ITMI20130793A1 (it) * 2013-05-14 2014-11-15 Probiotical Spa Composizione comprendente batteri lattici per uso nel trattamento preventivo e/o curativo delle cistiti ricorrenti.
JP5765832B2 (ja) * 2013-12-26 2015-08-19 雪印メグミルク株式会社 加齢に伴う代謝異常症の予防・改善・治療剤
CA2963213C (fr) * 2014-10-01 2021-02-09 Triphase Pharmaceuticals Pvt. Ltd. Souches de lactobacillus thermostables, produits et methodes associes
ITUB20155752A1 (it) 2015-11-19 2017-05-19 Probiotical Spa Composizione di batteri per uso per attenuare le diminuzioni di prestazione dopo un esercizio fisico che danneggia i muscoli.
ITUA20162013A1 (it) 2016-03-24 2017-09-24 Probiotical Spa Composizione a base di batteri lattici per il trattamento contemporaneo di infezioni vaginali di origine micotica e batterica.
CN107868776A (zh) 2016-09-23 2018-04-03 武汉康复得生物科技股份有限公司 糖基化草酸脱羧酶及其制备和应用
US11179426B2 (en) 2016-12-29 2021-11-23 Kibow Biotech, Inc. Composition and method for maintaining healthy kidney function
US12421518B2 (en) 2018-12-10 2025-09-23 Tenza, Inc. Methods and compositions for treating hyperoxaluria
BR112022013867A2 (pt) * 2020-01-14 2022-09-13 Synlogic Operating Co Inc Bactérias manipuladas para tratar distúrbios nos quais o oxalato é prejudicial
CN113308416B (zh) * 2021-07-20 2023-02-24 四川大学 一株具有抑制肾结石形成能力的植物乳杆菌及其应用
CN115851508B (zh) * 2022-10-13 2024-01-09 山东中科嘉亿生物工程有限公司 一种降草酸、改善肾结石的嗜热链球菌jyst-26及其产品、应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5810520A (ja) * 1981-07-10 1983-01-21 Miyarisan Kk 胆石症の治療薬
DE69219768T2 (de) * 1992-07-06 1997-08-28 Societe Des Produits Nestle S.A., Vevey Milchbakterien
IT1283225B1 (it) * 1996-03-11 1998-04-16 Renata Maria Anna Ve Cavaliere Ceppi di batteri, composizione farmaceutica contenente uno o piu' di tali ceppi e uso dei medesimi per la prevenzione e la terapia delle
ATE169456T1 (de) * 1996-12-23 1998-08-15 Sitia Yomo Spa Lyophilisierte, lebende bakerien enthaltende nahrungszusammensetzung
JP4996780B2 (ja) * 1997-05-23 2012-08-08 オクセラ インコーポレイテッド シュウ酸塩関連疾患を予防するためのシュウ酸塩分解微生物またはシュウ酸塩分解酵素
RU2139346C1 (ru) * 1999-03-02 1999-10-10 Шендеров Борис Аркадьевич Штамм бактерий lactobacillus plantarum, обладающий способностью снижать уровень оксалата и используемый для приготовления препаратов и продуктов питания для профилактики и лечения гипероксалурии

Also Published As

Publication number Publication date
WO2000072855A3 (fr) 2001-06-28
CA2373255C (fr) 2010-01-19
HK1048066A1 (zh) 2003-03-21
KR100781703B1 (ko) 2007-12-03
US6562336B2 (en) 2003-05-13
IT1309427B1 (it) 2002-01-23
ES2219344T3 (es) 2004-12-01
CA2373255A1 (fr) 2000-12-07
NZ516020A (en) 2003-06-30
EE200100618A (et) 2003-02-17
SI1181027T1 (en) 2004-08-31
PT1181027E (pt) 2004-09-30
IL199437A0 (en) 2011-07-31
BR0011038A (pt) 2002-02-26
DK1181027T3 (da) 2004-08-16
JP2003500451A (ja) 2003-01-07
HU225134B1 (en) 2006-06-28
UA71621C2 (en) 2004-12-15
TR200103439T2 (tr) 2002-06-21
BR0011038B1 (pt) 2014-02-18
ATE265857T1 (de) 2004-05-15
MXPA01012184A (es) 2003-06-30
SK16612001A3 (sk) 2002-04-04
KR20020019918A (ko) 2002-03-13
WO2000072855A2 (fr) 2000-12-07
EA004257B1 (ru) 2004-02-26
USRE39585E1 (en) 2007-04-24
JP4737836B2 (ja) 2011-08-03
IS6150A (is) 2001-11-08
EA200101262A1 (ru) 2002-04-25
DE60010456D1 (de) 2004-06-09
EP1181027B1 (fr) 2004-05-06
AU773459B2 (en) 2004-05-27
ITRM990338A0 (it) 1999-05-28
HUP0201409A3 (en) 2004-10-28
AU5101600A (en) 2000-12-18
DE60010456T2 (de) 2005-05-12
IL199437A (en) 2016-10-31
CN100350919C (zh) 2007-11-28
IL146703A0 (en) 2002-07-25
US20020061292A1 (en) 2002-05-23
HUP0201409A2 (en) 2002-08-28
AR024555A1 (es) 2002-10-16
NO20015782L (no) 2002-01-25
CN1365284A (zh) 2002-08-21
ZA200110504B (en) 2002-09-25
IL146703A (en) 2010-03-28
CZ20014076A3 (cs) 2002-03-13
MA26790A1 (fr) 2004-12-20
PL352014A1 (en) 2003-07-14
HK1048066B (zh) 2008-08-01
ITRM990338A1 (it) 2000-11-28
EP1181027A2 (fr) 2002-02-27
NO20015782D0 (no) 2001-11-27

Similar Documents

Publication Publication Date Title
DZ3165A1 (fr) Composition alimentaire ou pharmaceutique utiliseepour prevenir ou traiter l'hyperoxalurie.
DZ2494A1 (fr) Composition pharmaceutique d'oméprazole.
DZ3191A1 (fr) Composés d'indazole et compositions pharmaceutiques inhibant les protéines kinases, et procédés d'utilisation de ceux-ci.
DZ2887A1 (fr) Dérivés d'azétidine, leur préparation et les médicaments les contenant.
IL146119A0 (en) Novel medicament compositions, based on anticholinergically effective compounds and beta-mimetics
FR2805818B1 (fr) Derives d'azetidine, leur preparation et les compositions pharmaceutiques les contenant
MA26548A1 (fr) Compositions pharmaceutiques topiques contenant des derives de resorcinol.
EE200000468A (et) Ühendid, nende kasutamine ja farmatseutiline kompositsioon
DZ2964A1 (fr) Diphénylurées substituées nouvelles, et compositions pharmaceutiques les contenant.
BR9710372B1 (pt) composto, e, composiÇço farmacÊutica.
FR2705566B1 (fr) Nouvelles compositions pharmaceutiques.
BR0014465B1 (pt) 1,1'-bifenil-2-carbonamidas 2'-substituÍdas, preparado farmacÊutico e aplicaÇÕes dos referidos compostos.
WO2000066104A3 (fr) Composes inhibant ace-2 et leurs procedes d'utilisation
ITMI981774A0 (it) Composizioni farmaceutiche ad attivita' analgesica
KR100547921B1 (ko) 설폰아미드-치환된크로만,이의제조방법및이를포함하는약제학적조성물
ZA9811445B (en) Aminobiguanides and the use thereof to disinfect contact lenses and preserve pharmaceutical compositions.
EA199700032A1 (ru) Дезинфицирующий состав "велтолен"
ZA200203077B (en) Ciclesonide contained pharmaceutical composition for application to mucosa.
FR2703995B1 (fr) 5-acylamino 1,2,4-thiadiazoles, leur preparation et compositions pharmaceutiques en contenant.
BR9814945A (pt) Utilização de fanquinona para o tratamento de doença de alzheimer, composição farmacêutica e kit
EE04811B1 (et) Asendatud 3-fenüül-5-alkoksü-1,3,4-oksdiasool-2-oon, selle valmistamine ja kasutamine lipaasi inhibiitorina ning seda sisaldav ravim
DZ2867A1 (fr) Compositions pharmaceutiques comprenant des inhibiteurs de nos, leur préparation et leur utilisation.
NO20014692D0 (no) 3-amidinobenzensulfonamidderivater, medisinske sammensetninger inneholdende slike samt intermediater vedfremstillingen derav
MA26604A1 (fr) Compositions pharmaceutiques.
ITRM920305A1 (it) Composizione farmaceutica per il trattamento dello shock, particolarmente dello shock cardiogeno e dello shock settico.